Join to View Full Profile
8081 Innovation Park DrLevel 4 - White Oak ClinicFairfax, VA 22031
Phone+1 571-472-1380
Fax+1 571-472-1294
Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2007 - 2010
St Luke's HospitalResidency, Internal Medicine, 2003 - 2006
Sri Ramachandra Medical CollegeClass of 2000
Certifications & Licensure
MO State Medical License 2006 - 2026
VA State Medical License 2021 - 2026
KS State Medical License 2015 - 2025
TN State Medical License 2012 - 2018
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Start of enrollment: 2011 Apr 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Inhaled Chemotherapy.Janakiraman Subramanian, Rajiv Dhand
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2025-04-01 - CGE25-111: Enhancing Oncology Treatment Personalization through Plasma Proteomics and Machine Learning.Kimberly McGregor, Michal Harel, Adam P Dicker, Janakiraman Subramanian, Edgardo S Santos
Journal of the National Comprehensive Cancer Network. 2025-03-28 - EGFR testing practices, treatment choice and clinical outcomes in advanced NSCLC in a real-world setting: A retrospective analysis of a US-based electronic health reco...Janakiraman Subramanian, Jeffrey Gregg, Mehmet Berktas, Jingyi Li, Natasha B Leighl
Lung Cancer. 2025-03-01
Press Mentions
The Role of Chemotherapy in the Treatment of Stage II Nasopharyngeal Carcinoma: Retrospective Analysis of the National Cancer DatabaseFebruary 21st, 2020
Genomic Testing Solves Cancer MisdiagnosisMarch 14th, 2019
Lantern Pharma Announces Positive Clinical Update from Ongoing Phase 2 HARMONIC™ Clinical Trial for Never Smokers with Advanced NSCLC, Including an 86% Clinical Benefit Rate in the Initial Patient CohortAugust 8th, 2024
Professional Memberships
- Member
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
